Skip to content
★ Sign in to follow
SY

Sun Yong

Executive
Harvard Bioscience IncShanghai XNG Holdings Ltd.
Total declarations
18
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 03 Jan 2019 for HARVARD BIOSCIENCE INC, €54k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Sun Yong: trading record in brief

Sun Yong has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Harvard Bioscience Inc and Shanghai XNG Holdings Ltd. We count 18 filings; the first trade dates from 4 June 2015 and the latest from 1 January 2019.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 3 January 2019 came the latest disclosure, a share grant for €54k in Harvard Bioscience Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Sun Yong

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    61,498 USD12SEC
    19,339 shares@ US$3.185.8% of flowCommon StockSEC:0001209191-19-000896:0
  • ●
    DirectorExecutivesShanghai XNG Holdings Ltd.
    0HKEX
    4,142,066 sharesShareXHKGHKEX:DA20181211E00187
  • ◇
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    215,500 USD13SEC
    50,000 shares@ US$4.3120.6% of flowCommon StockSEC:0001209191-18-046795:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    249,960 USD13SEC
    37,588 shares@ US$6.6523.9% of flowCommon StockSEC:0001209191-18-046795:1
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    11,645 USD11SEC
    2,043 shares@ US$5.701.1% of flowCommon StockSEC:0001209191-18-046412:0
  • ◇
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    215,500 USD13SEC
    50,000 shares@ US$4.3120.0% of flowCommon StockSEC:0001209191-18-045094:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    236,061 USD13SEC
    41,054 shares@ US$5.7521.9% of flowCommon StockSEC:0001209191-18-045094:1
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    0SEC
    22,500 shares0Common StockSEC:0001209191-18-033845:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    0SEC
    22,500 shares0Common StockSEC:0001209191-18-033845:1
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    0SEC
    8,888 shares0Common StockSEC:0001209191-18-018918:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    11,426 USD11SEC
    2,539 shares@ US$4.501.0% of flowCommon StockSEC:0001209191-18-018918:1
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    63,947 USD12SEC
    19,378 shares@ US$3.305.6% of flowCommon StockSEC:0001209191-18-001632:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    0SEC
    109,130 shares0Common StockSEC:0001209191-17-036311:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    30,262 USD11SEC
    9,922 shares@ US$3.053.0% of flowCommon StockSEC:0001209191-17-000977:0
  • ◆
    VP - Commercial OperationsExecutivesHarvard Bioscience Inc
    0SEC
    89,007 shares0Common StockSEC:0001209191-16-118788:0
  • ◆
    VP - Strategic Marketing, R&DExecutivesHarvard Bioscience Inc
    0SEC
    1,609 sharesCommon StockSEC:0001209191-16-089005:0
  • ◆
    VP - Strategic Marketing, R&DExecutivesHarvard Bioscience Inc
    0SEC
    14,058 shares0Common StockSEC:0001209191-15-064203:0
  • ◆
    VP - Strategic Marketing, R&DExecutivesHarvard Bioscience Inc
    0SEC
    17,225 shares0Common StockSEC:0001209191-15-051058:0

18 of 18 declarations